Article
Cell Biology
Qi Sun, Yujie Wang, Hong Ji, Xiaoting Sun, Sisi Xie, Longtian Chen, Sen Li, Weifan Zeng, Ruibo Chen, Qi Tang, Ji Zuo, Likun Hou, Kayoko Hosaka, Yongtian Lu, Ying Liu, Ying Ye, Yunlong Yang
Summary: Nasopharyngeal carcinoma (NPC) patients have intrinsic resistance to antiangiogenic drugs (AADs), with FGF-2 expression triggering VEGF-independent angiogenesis as a mechanism. Lenvatinib, a multi-kinase inhibitor targeting VEGFR2 and FGFR1, effectively inhibits tumor vasculature and shows strong anti-tumor effects in NPC.
CELL DEATH & DISEASE
(2022)
Article
Biochemistry & Molecular Biology
Yu Jin Kim, Jang Mi Han, Hye Jin Jung
Summary: The study demonstrated the potent inhibitory effects of berbamine on VEGF and BDNF-induced angiogenesis, without affecting endothelial cell viability. Berbamine suppressed angiogenesis by regulating specific signaling pathways and key regulators in GBM cells, suggesting its potential as a new antiangiogenic agent for the treatment of malignant brain tumors.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(2021)
Article
Medicine, Research & Experimental
Dhanashri Deshmukh, Ya Fen Hsu, Chien-Chih Chiu, Mahendra Jadhao, Sodio C. N. Hsu, Shao-Yang Hu, Shu-Hui Yang, Wangta Liu
Summary: This study evaluated the antiangiogenic effects of Lepista nuda water extract on zebrafish development and in vitro human umbilical vein endothelial cell (HUVEC) tube formation. Bioactive components such as ergothioneine, eritadenine, and adenosine were identified and quantified. The results suggest that L. nuda could be a potential inhibitor of angiogenesis limiting cancer progression.
BIOMEDICINE & PHARMACOTHERAPY
(2023)
Article
Cardiac & Cardiovascular Systems
Cesar Rios-Navarro, Luisa Hueso, Ana Diaz, Victor Marcos-Garces, Clara Bonanad, Amparo Ruiz-Sauri, Jose M. Vila, Maria J. Sanz, Francisco J. Chorro, Laura Piqueras, Vicente Bodi
Summary: The study investigates the role of antiangiogenic isoform VEGF-A(165)b after myocardial infarction (MI) and its potential as a coadjuvant therapy to coronary reperfusion. Blocking VEGF-A(165)b enhances neoangiogenesis, reduces infarct size, and increases ejection fraction in reperfused MI experiments. Higher VEGF-A(165)b levels are associated with worse systolic function both experimentally and clinically.
REVISTA ESPANOLA DE CARDIOLOGIA
(2021)
Article
Pharmacology & Pharmacy
Renata A. de Abrantes, Tatianne M. Batista, Vivianne M. Mangueira, Tatyanna K. G. de Sousa, Rafael C. Ferreira, Ana Paula G. Moura, Lucas S. Abreu, Adriano F. Alves, Eudes S. Velozo, Leonia M. Batista, Marcelo S. da Silva, Josean F. Tavares, Marianna V. Sobral
Summary: The study investigated the in vivo antitumor action and toxicity of Tonantzitlolone B (TNZ-B), revealing its significant antitumor and antiangiogenic effects by reducing ROS and NO levels, with weak dose-repeated toxicity. These findings contribute to understanding the antitumor action of TNZ-B and suggest further studies with this natural compound as a potential anticancer drug.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Miguel A. Tejada, Ana I. Santos-Llamas, Maria Jose Fernandez-Ramirez, Juan J. Tarin, Antonio Cano, Raul Gomez
Summary: Studies in mouse models have shown that D2-ags and anti-VEGF compounds can significantly reduce the size and vascular density of endometriosis lesions, opening up possibilities for future application in human treatment.
Article
Oncology
Liting Xue, Xingyuan Gao, Haoyu Zhang, Jianxing Tang, Qian Wang, Feng Li, Xinxin Li, Xiaohong Yu, Zhihong Lu, Yue Huang, Renhong Tang, Wenqing Yang
Summary: The study demonstrates that BD0801 has stronger anti-tumor activity by blocking VEGF/VEGFR binding and inhibiting HUVECs. Combining BD0801 with anti-PD-1 or anti-PD-L1 antibodies shows synergistic anti-tumor efficacy in lung and colorectal cancer mouse models. Mechanistic studies suggest that the synergy involves improved tumor vasculature normalization and enhanced T-cell mediated immunity.
Article
Pharmacology & Pharmacy
Amr Hassan, Dalia Elebeedy, Emadeldin R. Matar, Aly Fahmy Mohamed Elsayed, Ahmed I. Abd El Maksoud
Summary: This study fabricated green zinc oxide nanorods using albumin eggshell as a bio-template and investigated its angiogenic potential through experiments. The results demonstrated that zinc oxide nanorods induce angiogenesis through mechanisms such as inducing VEGF expression, providing a new approach for developing materials for wound healing.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Chemistry, Medicinal
Shubhankar Gadre, M. Manikandan, Gourav Chakraborty, Amey Rayrikar, Subhadeep Paul, Chinmoy Patra, Malay Patra
Summary: This study synthesized a library of organo-Ir-III half-sandwich complexes and identified two lead candidates, compounds 5 and 6, which showed excellent anticancer activity and overcame platinum drug resistance. Compound 6 also had antiangiogenic properties. Compared to cisplatin and other Ir-III complexes, compound 6 exhibited higher antitumor efficacy in mouse and zebrafish models.
JOURNAL OF MEDICINAL CHEMISTRY
(2023)
Article
Oncology
Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer, Kati Erdmann, Susanne Fuessel, Theresa Link, Andreas du Bois, Stefan Kommoss, Florian Heitz, Jalid Sehouli, Rainer Kimmig, Nikolaus de Gregorio, Barbara Schmalfeldt, Tjoung-Won Park-Simon, Klaus Baumann, Felix Hilpert, Marcel Grube, Willibald Schroder, Alexander Burges, Antje Belau, Lars Harser, Jan Dominik Kuhlmann
Summary: A study on 413 patients from the ICON7 trial found that the addition of bevacizumab to standard platinum-based chemotherapy significantly improved survival rates in patients with low expression of VEGF-A165b.
CLINICAL CANCER RESEARCH
(2022)
Review
Cell Biology
Rahul Mallick, Seppo Ylae-Herttuala
Summary: Coronary heart disease (CHD) is a leading cause of death worldwide. This review article discusses the potential therapeutic role of VEGF-B, a novel member of the VEGF family, in treating CHD and heart failure. Key differences between the effects of VEGF-A and VEGF-B on endothelial functions are also highlighted.
Article
Oncology
Krzysztof Piersiala, Eric Hjalmarsson, Pedro Farrajota Neves da Silva, Vilma Lagebro, Aeneas Kolev, Magnus Starkhammar, Alexandra Elliot, Linda Marklund, Eva Munck-Wikland, Gregori Margolin, Susanna Kumlien Georen, Lars-Olaf Cardell
Summary: It has been established that T cells play a significant role in anti-tumor immune response, while the contribution of B cells has been insufficiently studied. In this research, the proportions and characteristics of B cells in tumor draining lymph nodes (TDLNs) and non-TDLNs from oral squamous cell carcinoma patients were analyzed. The results showed that TDLNs had a higher proportion of B cells, especially immunosuppressive regulatory B cells, compared to non-TDLNs. The presence of regulatory B cells in TDLNs may hinder the effectiveness of novel cancer immunotherapies in head and neck cancer.
INTERNATIONAL JOURNAL OF CANCER
(2023)
Review
Immunology
Jingwen Xiong, Hao Chi, Guanhu Yang, Songyun Zhao, Jing Zhang, Lisa Jia Tran, Zhijia Xia, Fang Yang, Gang Tian
Summary: B cells play a crucial role in the immune system by working with T cells to either suppress or promote tumor growth within the tumor microenvironment (TME). Through the release of exosomes, small membrane vesicles, B cells and other cells facilitate intercellular communication in the TME. Exosome research has shown that they carry molecules such as major histocompatibility complex (MHC) molecules and integrins, which regulate the TME. Therefore, targeting substances within the TME has emerged as a promising approach for cancer therapy. This review provides a comprehensive overview of the contributions of B cells and exosomes to the TME, as well as the potential role of B cell-derived exosomes in cancer progression.
FRONTIERS IN IMMUNOLOGY
(2023)
Review
Immunology
Ziwen Zhong, Ke Nan, Meilin Weng, Ying Yue, Wenchang Zhou, Zhiqiang Wang, Yiwei Chu, Ronghua Liu, Changhong Miao
Summary: In this review, emerging evidence regarding the production and effects of IgA and IgA(+) cells in the tumor microenvironment (TME) is summarized. Furthermore, the role of TME cytokines, host diet, microbiome, and metabolites in controlling the class-switch recombination (CSR) of IgA is discussed. The analysis of intratumoral Ig repertoires and determination of metabolites that influence CSR may help establish novel therapeutic targets for the treatment of cancers.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Pharmacology & Pharmacy
Suzana Carvalho, Maria Jose Silveira, Mariana Domingues, Barbara Ferreira, Catarina Leite Pereira, Maria Palmira Gremiao, Bruno Sarmento
Summary: This study proposes a multicellular spheroid model of colorectal cancer (CRC) for screening the antiangiogenic potential of novel nanomedicines. The developed model consists of HCT116 cells, human pulmonary microvascular endothelial cell (HPMEC), fibroblasts, and macrophages. It exhibits intrinsic CRC features and shows that Gellan gum/chitosan nanoparticles encapsulating BVZ have superior antiangiogenic properties compared to free BVZ.
ADVANCED THERAPEUTICS
(2023)